Thalamic and caudate volumes in monozygotic twins discordant for schizophrenia

被引:28
作者
Bridle, N
Pantelis, C [1 ]
Wood, SJ
Coppola, R
Velakoulis, D
McStephen, M
Tierney, P
Le, TL
Torrey, EF
Weinberger, DR
机构
[1] Univ Melbourne, Cognit Neuropsychiat Res & Acad Unit, Parkville, Vic 3052, Australia
[2] Mental Hlth Res Inst Victoria, Parkville, Vic, Australia
[3] NIMH, Clin Brain Disorders Branch, Bethesda, MD 20892 USA
关键词
caudate nucleus; magnetic resonance imaging; schizophrenia; thalamus; twins;
D O I
10.1046/j.1440-1614.2001.01022.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The thalamus and caudate nucleus are key subcortical structures in the fronto-striato-thalamic pathways that have been implicated in the pathogenesis of schizophrenia. Previous studies have been inconsistent in identifying structural and functional abnormalities in these structures. However, methodologies in these studies have been unreliable and some have not adequately matched patients and controls. Methods: Using algebraically-manipulated double-echo magnetic resonance (MR) images, we developed a reliable method to estimate caudate and thalamic volumes in a group of 13 monozygotic (MZ) twins; eight discordant for schizophrenia and five normal. Initially, volumes were measured on four image types: proton density (PD), T2-weighted, summed (PD + T2) and subtracted (PD-T2) to determine the most reliable method. Results: There was a significant method by region interaction, where caudate volumes measured on PD images were significantly larger than those measured on T2-weighted images, while the opposite was found for thalamic volumes. However, there was no interaction of method by diagnosis. Test-retest reliability was highest for the summed images. Using summed images to measure the volumes of the caudate and thalamus in each twin, we found significantly increased caudate volumes in affected twins compared to their unaffected cotwins, but no significant difference in thalamic volume. Conclusions: Our results in a small sample of MZ twins discordant for schizophrenia do not support the presence of structural abnormalities in the thalamus. The findings in the caudate are consistent with previously reported effects of antipsychotic medication. We also report a reliable method for assessing the volumes of subcortical structures. However, volumetric estimates of brain structures may be dependent on which method is used and the structure being assessed. Such interactions need to be considered in future studies investigating brain structural abnormalities in schizophrenia and other disorders.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 40 条
[1]   FUNCTIONAL ARCHITECTURE OF BASAL GANGLIA CIRCUITS - NEURAL SUBSTRATES OF PARALLEL PROCESSING [J].
ALEXANDER, GE ;
CRUTCHER, MD .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :266-271
[2]   THALAMIC ABNORMALITIES IN SCHIZOPHRENIA VISUALIZED THROUGH MAGNETIC-RESONANCE IMAGE AVERAGING [J].
ANDREASEN, NC ;
ARNDT, S ;
SWAYZE, V ;
CIZADLO, T ;
FLAUM, M ;
OLEARY, D ;
EHRHARDT, JC ;
YUH, WTC .
SCIENCE, 1994, 266 (5183) :294-298
[3]   Hypofrontality in schizophrenia: Distributed dysfunctional circuits in neuroleptic-naive patients [J].
Andreasen, NC ;
OLeary, DS ;
Flaum, M ;
Nopoulos, P ;
Watkins, GL ;
Ponto, LLB ;
Hichwa, RD .
LANCET, 1997, 349 (9067) :1730-1734
[4]  
ANDREASEN NC, 1990, ARCH GEN PSYCHIAT, V47, P35
[5]   The thalamus and the schizophrenia phenotype: Failure to replicate reduced volume [J].
Arciniegas, D ;
Rojas, DC ;
Teale, P ;
Sheeder, J ;
Sandberg, E ;
Reite, M .
BIOLOGICAL PSYCHIATRY, 1999, 45 (10) :1329-1335
[6]   POSITRON EMISSION TOMOGRAPHY STUDIES OF BASAL GANGLIA AND SOMATOSENSORY CORTEX NEUROLEPTIC DRUG EFFECTS - DIFFERENCES BETWEEN NORMAL CONTROLS AND SCHIZOPHRENIC-PATIENTS [J].
BUCHSBAUM, MS ;
WU, JC ;
DELISI, LE ;
HOLCOMB, HH ;
HAZLETT, E ;
COOPERLANGSTON, K ;
KESSLER, R .
BIOLOGICAL PSYCHIATRY, 1987, 22 (04) :479-494
[7]  
BUCHSBAUM MS, 1992, ARCH GEN PSYCHIAT, V49, P935
[8]  
Buchsbaum MS, 1996, AM J PSYCHIAT, V153, P191
[9]  
CEDERLOEF R, 1961, ACTA GENET STAT MED, V11, P338
[10]   CAUDATE NUCLEI VOLUMES IN SCHIZOPHRENIC-PATIENTS TREATED WITH TYPICAL ANTIPSYCHOTICS OR CLOZAPINE [J].
CHAKOS, MH ;
LIEBERMAN, JA ;
ALVIR, J ;
BILDER, R ;
ASHTARI, M .
LANCET, 1995, 345 (8947) :456-457